These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25139589)

  • 21. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain.
    Wallace MS; Rowbotham MC; Katz NP; Dworkin RH; Dotson RM; Galer BS; Rauck RL; Backonja MM; Quessy SN; Meisner PD
    Neurology; 2002 Dec; 59(11):1694-700. PubMed ID: 12473754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study.
    Silberstein S; Saper J; Berenson F; Somogyi M; McCague K; D'Souza J
    Neurology; 2008 Feb; 70(7):548-55. PubMed ID: 18268247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain.
    Silver M; Blum D; Grainger J; Hammer AE; Quessy S
    J Pain Symptom Manage; 2007 Oct; 34(4):446-54. PubMed ID: 17662571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial.
    Holbech JV; Otto M; Bach FW; Jensen TS; Sindrup SH
    Eur J Pain; 2011 Jul; 15(6):608-14. PubMed ID: 21183370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale and evidence for the use of oxcarbazepine in neuropathic pain.
    Carrazana E; Mikoshiba I
    J Pain Symptom Manage; 2003 May; 25(5 Suppl):S31-5. PubMed ID: 12694990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment.
    Serpell M; Ratcliffe S; Hovorka J; Schofield M; Taylor L; Lauder H; Ehler E
    Eur J Pain; 2014 Aug; 18(7):999-1012. PubMed ID: 24420962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of oxcarbazepine in the treatment of painful diabetic neuropathy.
    Beydoun A; Kobetz SA; Carrazana EJ
    Clin J Pain; 2004; 20(3):174-8. PubMed ID: 15100593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxcarbazepine is effective and safe in the treatment of neuropathic pain: pooled analysis of seven clinical studies.
    Magenta P; Arghetti S; Di Palma F; Jann S; Sterlicchio M; Bianconi C; Galimberti V; Osio M; Siciliano G; Cavallotti G; Sterzi R
    Neurol Sci; 2005 Oct; 26(4):218-26. PubMed ID: 16193248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (PXN110748).
    Zhang L; Rainka M; Freeman R; Harden RN; Bell CF; Chen C; Graff O; Harding K; Hunter S; Kavanagh S; Laurijssens B; Schwartzbach C; Warren S; McClung C
    J Pain; 2013 Jun; 14(6):590-603. PubMed ID: 23602345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.
    Sindrup SH; Andersen G; Madsen C; Smith T; Brøsen K; Jensen TS
    Pain; 1999 Oct; 83(1):85-90. PubMed ID: 10506675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A spicamycin derivative (KRN5500) provides neuropathic pain relief in patients with advanced cancer: a placebo-controlled, proof-of-concept trial.
    Weinstein SM; Abernethy AP; Spruill SE; Pike IM; True Kelly A; Jett LG
    J Pain Symptom Manage; 2012 Apr; 43(4):679-93. PubMed ID: 21983265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydromorphone extended release for neuropathic and non-neuropathic/nociceptive chronic low back pain: a post hoc analysis of data from a randomized, multicenter, double-blind, placebo-controlled clinical trial.
    Nalamachu S; Hale M; Khan A
    J Opioid Manag; 2014; 10(5):311-22. PubMed ID: 25350473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulsed magnetic field therapy in refractory neuropathic pain secondary to peripheral neuropathy: electrodiagnostic parameters--pilot study.
    Weintraub MI; Cole SP
    Neurorehabil Neural Repair; 2004 Mar; 18(1):42-6. PubMed ID: 15035963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial.
    Gilron I; Wajsbrot D; Therrien F; Lemay J
    Clin J Pain; 2011; 27(3):185-93. PubMed ID: 21178603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin.
    Criscuolo S; Auletta C; Lippi S; Brogi F; Brogi A
    Acta Neurol Scand; 2005 Apr; 111(4):229-32. PubMed ID: 15740573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.
    Schwartz S; Etropolski M; Shapiro DY; Okamoto A; Lange R; Haeussler J; Rauschkolb C
    Curr Med Res Opin; 2011 Jan; 27(1):151-62. PubMed ID: 21162697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
    Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
    Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component.
    Yousef AA; Al-deeb AE
    Anaesthesia; 2013 Mar; 68(3):260-6. PubMed ID: 23384256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of 1.5% Topical Diclofenac on Clinical Neuropathic Pain.
    Ahmed SU; Zhang Y; Chen L; Cohen A; St Hillary K; Vo T; Houghton M; Mao J
    Anesthesiology; 2015 Jul; 123(1):191-8. PubMed ID: 25955980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.